Well we are well and truly merged with the pharmaceutival gigantaurs NABI and have been trading on the NASDAQ for over half a year. Here is the report card:
Strategy: 1/10 well at least plumb delivered a strategic review. It was late, it wasn't communicated to the investing public, & it failed to highlight the potential of any of our pipeline of products. The market yawned.
Marketing / PR: 0/10 clearly mgmt haven't taken onboard feedback from past shareholders and see no reason to communicate Biota's array of exciting products. Result is low liquidity and record low share price.
Accountability: 0/10 Chairman Fox sold us the on the untold riches we would get from merging with NABi and abandoning the Aussie sharemarket. He was dismissive of any opposition. We haven't heard a peep from him since the merger.
Remaning long suffering Aussie shareholder please feel free to add to this report card
6 month report card: us only listing
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)